Get Fit Bharat

Tag: Resistance

HomeResistance

RHI Magnesita India Limited, the leading manufacturer and supplier of high-grade refractory products, systems, and solutions, today announced the inauguration of its new Regional Corporate Office in Gurugram, latest in the series of significant investments in India to drive business growth in the region, marking a significant milestone in the company’s growth journey.   …

Tue, Nov 19, 2024 08:15 CET Report this content BiBBInstruments takes another step in the clinical evaluation of EndoDrill GI. Recently, Sahlgrenska University Hospital in Gothenburg joined the growing group of clinics evaluating the instrument. BioStock contacted the company’s founder and CMO Charles Walther to get his thoughts. …

Nashville, Tenn., United States:  CONNECTIONS CONFERENCE – Guidewire (NYSE: GWRE) will showcase its commitment to improving risk selection and pricing, indemnity management, and claims efficiency in property and casualty insurance at its annual customer conference, Connections. The event will unveil future underwriting and claims application capabilities enhanced by AI, introduce Claims …

The centre is expected to serve 10,000 patients in the region with transformative cleft care in the first three years of operations. Gothenburg, Sweden. 19 November 2024. The Cebu Comprehensive Cleft Care Center of Excellence is now officially inaugurated. This milestone is a result of the longstanding partnership between Mölnlycke …

Top executives from the IT distribution and technology vendor sectors convened today at the inaugural GTDC APJ- Summit 2024 to discuss the current position and future outlook of these critical communities. The Summit underscored the essential role distributors play in scaling emerging technology sales and adoption and developing new opportunities through digital marketplaces and …

  Oslo, 19 November 2024. Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, today releases its third quarter 2024 results. Lytix achieved substantial progress in its clinical pipeline, progressing towards commercialization.   “Our progress this quarter underscores Lytix’s potential …